Vaccitech Promotes Gemma Brown as Chief Financial Officer
OXFORD, United Kingdom, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines, today announced the promotion of Gemma Brown as Chief Financial Officer (CFO). Gemma Brown succeeds Georgy Egorov.
“Gemma has been highly engaged with all financial activities at Vaccitech including working with our auditors, corporate budgeting, SEC financial filings and other activities so we anticipate a seamless transition,” said Bill Enright, Chief Executive Officer of Vaccitech. “I want to personally thank Georgy for his contributions to Vaccitech particularly his efforts that led to our successful IPO in 2021. We wish him the best in his future endeavors.”
Gemma Brown is an experienced financial executive who joined Vaccitech as its Head of Financial Reporting in 2021, before her promotion to CFO. In that role, she was responsible for the majority of the work related to quarterly/annual financial activities, compiling SEC filings, was a key contributor in other corporate finance activities and worked with her now predecessor to develop the annual corporate budget. Prior to joining Vaccitech, Gemma was at EY where she held positions of increasing responsibility, reaching the level of Senior Manager and participating in their accelerated leadership programs. While at EY, she worked with clients across the U.S. and UK capital markets and was responsible for servicing several emerging biopharmaceutical companies who achieved listings on Nasdaq, either through an initial public offering or M&A transaction, and subsequent follow-on capital raises. She holds a B.Sc. in Biological Sciences and is a Chartered Accountant with the Institute of Chartered Accountants in England & Wales.
“I have spent most of my career assisting emerging biopharmaceutical companies and am passionate about positioning them financially for future success,” said Gemma Brown, CFO.” I am looking forward to expanding my financial responsibilities at Vaccitech and working closely with Bill and the management team to continue to develop the company. I also want to thank Georgy for his guidance and support during our time working together.”
About Vaccitech plc
Forward Looking Statement
Vaccitech IR contact
Vaccitech Media contacts:
Increasing Profits through Managed Cybersecurity
IoT Evolution Expo #TECHSUPERSHOW Networking Live Party
Future of Work Expo #TECHSUPERSHOW Networking Live Party